This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Dr. Tebartz et al. misunderstand our manuscript.1 First, since our initial description of anti-NMDAR encephalitis, we have recommended CSF studies for patients with first-episode psychosis (FEP) of unclear etiology. Second, CSF studies are rarely performed in psychiatric facilities (as reviewed in Dalmau et al.2); thus, we provided an algorithm emphasizing those cases that, even in these facilities, should have CSF studies. Third, signs, symptoms, paraclinical features, and comorbidities of autoimmune encephalitis (AE) have been repurposed as red or yellow flags of autoimmune psychosis,3 and we agree that FEP patients with any of these AE features should have CSF studies. What we do criticize is the inclusion of these flags in the criteria developed to facilitate the diagnosis of autoimmune psychosis in patients with minimal or no features of AE because, in this setting, the criteria and flags are of very limited value.1
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received March 28, 2022.
- Accepted in final form March 28, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Association of Neurofilament Light With the Development and Severity of Parkinson Disease
Dr. Rodolfo Savica and Dr. Parichita Choudhury